ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

American Association for Cancer Research Presents Awards at 2012 Annual Meeting

April 6, 2012

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

June 27, 2003

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991

Nine New Grants Awarded In The NCI “Director’s Challenge”.

October 13, 2000

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001